NCT05898477View on ClinicalTrials.gov

Describing Treatment Outcomes and Responses in Lymphoma-associated Hemophagocytic Lymphohistiocytosis

RecruitingOBSERVATIONAL

Enrollment

2,000

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

January 31, 2026

Study Completion Date

July 31, 2026

Conditions

LymphomaHemophagocytic Lymphohistiocytoses

Trial Locations (1)

35294

RECRUITING

University of Alabama at Birmingham, Birmingham

All Listed Sponsors

lead

University of Alabama at Birmingham

OTHER